EXCAUGH
NDC 51467-009, Guaifenesin, tablet, from FORTUNE PHARMACAL COMPANY, LIMITED.
- Product NDC
- 51467-009
- Status
- Listed
- Labeler
- FORTUNE PHARMACAL COMPANY, LIMITED
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51467-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN100 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51467-009-01 | 51467000901 | 2 BLISTER PACK in 1 BOX (51467-009-01) / 12 TABLET in 1 BLISTER PACK |
| 51467-009-02 | 51467000902 | 3 BLISTER PACK in 1 BOX (51467-009-02) / 12 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51467-009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51467-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51467-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.